These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 9678434)

  • 1. Biocompatibility of a glucose-free, acidic lactated solution for peritoneal dialysis evaluated by population analysis of mesothelium.
    Wajsbrot V; Shostak A; Gotloib L; Kushnier R
    Nephron; 1998; 79(3):322-32. PubMed ID: 9678434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population analysis of mesothelium in situ and in vivo exposed to bicarbonate-buffered peritoneal dialysis fluid.
    Gotloib L; Wajsbrot V; Shostak A; Kushnier R
    Nephron; 1996; 73(2):219-27. PubMed ID: 8773348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High glucose induces a hypertrophic, senescent mesothelial cell phenotype after long in vivo exposure.
    Gotloib L; Shostak A; Wajsbrot V; Kushnier R
    Nephron; 1999 Jun; 82(2):164-73. PubMed ID: 10364709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute and long-term changes observed in imprints of mouse mesothelium exposed to glucose-enriched, lactated, buffered dialysis solutions.
    Gotloib L; Waisbrut V; Shostak A; Kushnier R
    Nephron; 1995; 70(4):466-77. PubMed ID: 7477654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesothelial dysplastic changes and lipid peroxidation induced by 7.5% icodextrin.
    Gotloib L; Wajsbrot V; Shostak A
    Nephron; 2002 Sep; 92(1):142-55. PubMed ID: 12187097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The in vitro biocompatibility performance of a 25 mmol/L bicarbonate/10 mmol/L lactate-buffered peritoneal dialysis fluid.
    Skoufos L; Topley N; Cooker L; Dawnay A; Millar DJ; Holmes CJ; Faict D
    Kidney Int Suppl; 2003 Dec; (88):S94-9. PubMed ID: 14870882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of hyperosmolality upon the mesothelial monolayer exposed in vivo and in situ to a mannitol-enriched dialysis solution.
    Gotloib L; Wajsbrot V; Shostak A; Kushnier R
    Nephron; 1999; 81(3):301-9. PubMed ID: 10050085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daily short exposure of cultured mesothelial cells to lactated, high-glucose, low-pH peritoneal dialysis fluid induces a low-profile regenerative steady state.
    Shostak A; Pivnik K; Gotloib L
    Nephrol Dial Transplant; 1996 Apr; 11(4):608-13. PubMed ID: 8671847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newly Developed Neutralized pH Icodextrin Dialysis Fluid: Nonclinical Evaluation.
    Yamaguchi N; Miyamoto K; Murata T; Ishikawa E; Horiuchi T
    Artif Organs; 2016 Aug; 40(8):E158-66. PubMed ID: 27530675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane.
    Mortier S; Faict D; Schalkwijk CG; Lameire NH; De Vriese AS
    Kidney Int; 2004 Sep; 66(3):1257-65. PubMed ID: 15327425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritoneal dialysis fluid-induced angiogenesis in rat mesentery is increased by lactate in the presence or absence of glucose.
    Albrektsson A; Bazargani F; Wieslander A; Braide M
    ASAIO J; 2006; 52(3):276-81. PubMed ID: 16760716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Icodextrin-induced lipid peroxidation disrupts the mesothelial cell cycle engine.
    Gotloib L; Wajsbrot V; Shostak A
    Free Radic Biol Med; 2003 Feb; 34(4):419-28. PubMed ID: 12566067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BIOKID: randomized controlled trial comparing bicarbonate and lactate buffer in biocompatible peritoneal dialysis solutions in children [ISRCTN81137991].
    Nau B; Schmitt CP; Almeida M; Arbeiter K; Ardissino G; Bonzel KE; Edefonti A; Fischbach M; Haluany K; Misselwitz J; Kemper MJ; Rönnholm K; Wygoda S; Schaefer F;
    BMC Nephrol; 2004 Oct; 5():14. PubMed ID: 15485574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dialysis solutions buffered with lactate or bicarbonate: in vitro comparison of two dialysis solutions on human peritoneal cell growth from ESRD and non-ESRD patients.
    Fougeray S; Slingeneyer A; Bastide JM; Mion C; Bastide M
    Adv Perit Dial; 1994; 10():235-40. PubMed ID: 7999836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved biocompatibility of bicarbonate/lactate-buffered PDF is not related to pH.
    Zareie M; Keuning ED; ter Wee PM; Schalkwijk CG; Beelen RH; van den Born J
    Nephrol Dial Transplant; 2006 Jan; 21(1):208-16. PubMed ID: 16263741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose degradation products (GDP) retard remesothelialization independently of D-glucose concentration.
    Morgan LW; Wieslander A; Davies M; Horiuchi T; Ohta Y; Beavis MJ; Craig KJ; Williams JD; Topley N
    Kidney Int; 2003 Nov; 64(5):1854-66. PubMed ID: 14531821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of new peritoneal dialysis solutions on leukocyte recruitment in the rat peritoneal membrane.
    Mortier S; Faict D; Gericke M; Lameire N; De Vriese A
    Nephron Exp Nephrol; 2005; 101(4):e139-45. PubMed ID: 16131808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heat sterilization of peritoneal dialysis solutions influences ingestive behavior in non-uremic rats.
    Zheng ZH; Anderstam B; Qureshi AR; Heimbürger O; Wang T; Södersten P; Bergström J; Lindholm B
    Kidney Int; 2002 Oct; 62(4):1447-53. PubMed ID: 12234318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of pH-neutral, bicarbonate-buffered dialysis fluid on peritoneal transport kinetics in children.
    Schmitt CP; Haraldsson B; Doetschmann R; Zimmering M; Greiner C; Böswald M; Klaus G; Passlick-Deetjen J; Schaefer F
    Kidney Int; 2002 Apr; 61(4):1527-36. PubMed ID: 11918761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic cytotoxicity of acidity and 3,4-Dideoxyglucosone-3-ene under the existence of lactate in peritoneal dialysis fluid.
    Tomo T; Okabe E; Yamamoto T; Namoto S; Iwashita T; Matsuyama K; Kadota J; Nasu M
    Ther Apher Dial; 2005 Apr; 9(2):182-7. PubMed ID: 15828932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.